Loading…
← Back to schedule
Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
Tuesday January 14, 2025 11:10am - 12:00pm PST
Hyatt Regency San Francisco
As clinical trials expand across borders, sponsors face unique challenges that can slow progress and increase complexity. This panel will dive into the key hurdles holding sponsors back, from navigating varying regulatory requirements to overcoming cultural and language barriers. Industry experts will explore strategies to streamline regulatory approvals, improve trial efficiency across diverse regions, and leverage cultural insights to enhance patient recruitment and retention. Join us for a deep dive into the opportunities and solutions driving the future of international clinical trials.
Moderators
avatar for Stephanie Butler

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →
Speakers
avatar for Judith Ng-Cashin, M.D.

Judith Ng-Cashin, M.D.

Chief Medical Officer, Novotech
Judith Ng-Cashin, M.D. joined Novotech in 2023 as its Chief Medical Officer. With a rich background encompassing over two decades in the international pharmaceutical, biotech, and CRO sectors, Dr. Ng-Cashin plays a pivotal role in shaping Novotech's global multi-regional later-phase... Read More →
avatar for Janet Hammond, MD, PhD

Janet Hammond, MD, PhD

Chief Development Officer, Atea Pharmaceuticals
Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities... Read More →
avatar for Eric A. Hughes, MD, PhD

Eric A. Hughes, MD, PhD

Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals
Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative... Read More →
avatar for Irfan Qureshi

Irfan Qureshi

Chief Medical Officer, Biohaven, Ltd
Irfan Qureshi, M.D., Chief Medical Officer, Biohaven (NYSE: BHVN) is a Board-certified neurologist with more than 20 years of experience in industry, academia, and patient care.Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing... Read More →
Tuesday January 14, 2025 11:10am - 12:00pm PST
Hyatt Regency San Francisco
  Panel

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Share Modal

Share this link via

Or copy link